FDA Philips CPAP MachinesAbout a month after the Food and Drug Administration (FDA) chided Philips for its “inadequate” recall response, lawyers from the Department of Justice subpoenaed documents in the case. Royal Philips CEO Frans van Houten said his company was cooperating with the agency. “They are preparing an investigation, and we just have to accept that,” he…